ETF Returns: Mid-Cap Winners And Losers
Portfolio Pulse from Johnny Rice
A screening of mid-cap ETFs revealed the largest positive and negative returns of the week. Winners included iShares U.S. Home Construction ETF (ITB) and Global X US Infrastructure Development ETF (PAVE), while losers were ARK Genomic Revolution ETF (ARKG) and SPDR S&P Biotech ETF (XBI). ITB and PAVE saw increases of 4.10% and 2.39% respectively, while ARKG and XBI saw decreases of 5.44% and 5.39% respectively.
June 28, 2023 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
iShares U.S. Home Construction ETF (ITB) is up 4.10% over the trailing week. It has 2.22 billion in AUM and an expense ratio of 0.39%. The fund's largest holdings are DR Horton, Inc (DHI) and Lennar Corporation Class A (LEN).
The positive return of ITB over the week indicates a positive short-term impact on the ETF. The performance of its largest holdings, DHI and LEN, could also be positively affected.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Global X US Infrastructure Development ETF (PAVE) is up 2.39% on the week. It has $4.53 billion in AUM and an expense ratio of 0.47%. The fund's largest holdings are Eaton Corp. Plc (ETN) and Parker-Hannifin Corporation (PH).
The positive return of PAVE over the week indicates a positive short-term impact on the ETF. The performance of its largest holdings, ETN and PH, could also be positively affected.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
ARK Genomic Revolution ETF (ARKG) is down 5.44% on the week. It has $2.06 billion in AUM and an expense ratio of .75%. The fund's largest holdings are Exact Sciences Corporation (EXAS) and Schrodinger, Inc. (SDGR).
The negative return of ARKG over the week indicates a negative short-term impact on the ETF. The performance of its largest holdings, EXAS and SDGR, could also be negatively affected.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
SPDR S&P Biotech ETF (XBI) is down 5.39% on the week. It has $6.39 billion in AUM and an expense ratio of .35%. The fund's largest holdings are Catalyst Pharmaceuticals, Inc. (CPRX) and Blueprint Medicines Corp. (BPMC).
The negative return of XBI over the week indicates a negative short-term impact on the ETF. The performance of its largest holdings, CPRX and BPMC, could also be negatively affected.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100